Dimethylethylcarbinol

CAS No. 75-85-4

Dimethylethylcarbinol( —— )

Catalog No. M19505 CAS No. 75-85-4

A branched pentanol used primarily as a pharmaceutical or pigment solvent.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Dimethylethylcarbinol
  • Note
    Research use only, not for human use.
  • Brief Description
    A branched pentanol used primarily as a pharmaceutical or pigment solvent.
  • Description
    A branched pentanol used primarily as a pharmaceutical or pigment solvent. It remains liquid at room temperature making it a useful alternative to tert-butyl alcohol. It is a colorless liquid with a pungent odor of camphor which is miscibile with both water and organic solvents.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    75-85-4
  • Formula Weight
    88.15
  • Molecular Formula
    C5H12O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:>10 mM
  • SMILES
    CCC(C)(C)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Anand JS et al. Forensic Sci Int. 2014 Sep;242:e31-3.
molnova catalog
related products
  • VT104

    VT104 is a potent and orally active YAP/TAZ inhibitor for cancer research. VT104 blocks palmitoylation of endogenous TEAD1 and TEAD3 proteins.

  • 3-(3,6-dichloro-9H-c...

    3-(3,6-dichloro-9H-carbazol-9-yl)propanoic acid is a compound used as a molecular building block.

  • Citreorosein

    Citreorosein is a cAMP phosphodiesterase inhibitor, it has anti-inflammatory effect, inhibits proinflammatory cytokines production through the inhibition of both MAPKs and AKT-mediated IκB kinase (IKK) phosphorylation and subsequent inhibition of transcription factor NF-κB activation.